NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Paroxetine effective and well-tolerated treatment of erythema of rosacea Dr. Mahalakshmi Sivashankaran31 March 2023 11:30 AM ISTChina: A new study has found that paroxetine, a medication commonly used to treat depression and anxiety, may be an effective and safe treatment for...
Desvenlafaxine, paroxetine, venlafaxine, and vortioxetine efficacious and acceptable in stable MDD Dr. Kamal Kant Kohli1 Nov 2022 8:00 PM ISTJAPAN: According to a study that was published in the Journal, Molecular Psychiatry, the antidepressants desvenlafaxine, paroxetine, venlafaxine, and...
Quetiapine, oxycodone combo doesn't significantly decrease ventilatory response to hypercapnia: JAMA Dr.Niharika Harsha B14 Oct 2022 12:00 PM ISTA new trial found that paroxetine combined with oxycodone significantly decreased the ventilatory response to hypercapnia on days 1 and 5 compared...
Paroxetine fails to improve LVEF after anterior MI: JAMA Dr. Shravani Dali5 Aug 2021 9:15 AM ISTParoxetine when administered to patients does not improve LVEF after anterior myocardial infarction, suggests a study published in JAMA Cardiology. ...
Common anti-depressant may be first-ever treatment for osteoarthritis Hina Zahid11 Feb 2021 6:00 PM ISTHERSHEY, Pa. - A disease of the joints, osteoarthritis affects more than 30 million adults and is the fifth-leading cause of disability in the United...
Jubilant Life gets USFDA nod for generic anti-depressant tablets savita thakur thakur2 Dec 2015 8:05 AM ISTNew Delhi: Jubilant Life Sciences Ltd has received final approval from the US health regulator for its generic version of anti-depressant Paxil...
